These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8918562)

  • 1. Persistent reduction in IL-6 mRNA in peripheral blood mononuclear cells of patients with rheumatoid arthritis after treatment with a monoclonal antibody to CD54 (ICAM-1).
    Schulze-Koops H; Lipsky PE; Kavanaugh AF; Davis LS
    Clin Exp Immunol; 1996 Nov; 106(2):190-6. PubMed ID: 8918562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated Th1- or Th0-like cytokine mRNA in peripheral circulation of patients with rheumatoid arthritis. Modulation by treatment with anti-ICAM-1 correlates with clinical benefit.
    Schulze-Koops H; Lipsky PE; Kavanaugh AF; Davis LS
    J Immunol; 1995 Nov; 155(10):5029-37. PubMed ID: 7594511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of interleukin-1 beta, tumor necrosis factor alpha, interleukins-6, -10 and -4, and metalloproteases by freshly isolated mononuclear cells from early never-treated and non-acute treated rheumatoid arthritis patients.
    Vázquez-Del Mercado M; Delgado-Rizo V; Muñoz-Valle JF; Orozco-Alcalá J; Volk HD; Armendáriz-Borunda J
    Clin Exp Rheumatol; 1999; 17(5):575-83. PubMed ID: 10544841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of monocyte-macrophage activation markers upon anti-CD4 treatment. Decreased levels of IL-1, IL-6, neopterin and soluble CD14 in patients with rheumatoid arthritis.
    Horneff G; Sack U; Kalden JR; Emmrich F; Burmester GR
    Clin Exp Immunol; 1993 Feb; 91(2):207-13. PubMed ID: 7679058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mononuclear cell retention in rheumatoid synovial tissue engrafted in severe combined immunodeficient (SCID) mice is up-regulated by tumour necrosis factor-alpha (TNF-alpha) and mediated through intercellular adhesion molecule-1 (ICAM-1).
    Jorgensen C; Couret I; Canovas F; Bologna C; Brochier J; Reme T; Lipsky P; Sany J
    Clin Exp Immunol; 1996 Oct; 106(1):20-5. PubMed ID: 8870693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated cytokine messenger RNA levels in the peripheral blood of patients with rheumatoid arthritis suggest different degrees of myeloid cell activation.
    Schulze-Koops H; Davis LS; Kavanaugh AF; Lipsky PE
    Arthritis Rheum; 1997 Apr; 40(4):639-47. PubMed ID: 9125245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral blood monocytes of rheumatoid arthritis patients do not express elevated TNF alpha, IL-1beta, and IL-8 mRNA levels. A comparison of monocyte isolation procedures.
    Rodenburg RJ; van den Hoogen FH; van de Putte LB; van Venrooij WJ
    J Immunol Methods; 1998 Dec; 221(1-2):169-75. PubMed ID: 9894908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of therapy with chimeric monoclonal tumour necrosis factor-alpha antibodies on intracellular cytokine profiles of T lymphocytes and monocytes in rheumatoid arthritis patients.
    Schuerwegh AJ; Van Offel JF; Stevens WJ; Bridts CH; De Clerck LS
    Rheumatology (Oxford); 2003 Apr; 42(4):541-8. PubMed ID: 12649401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo blockade of TNF-alpha by intravenous infusion of a chimeric monoclonal TNF-alpha antibody in patients with rheumatoid arthritis. Short term cellular and molecular effects.
    Lorenz HM; Antoni C; Valerius T; Repp R; Grünke M; Schwerdtner N; Nüsslein H; Woody J; Kalden JR; Manger B
    J Immunol; 1996 Feb; 156(4):1646-53. PubMed ID: 8568271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-18 enhances monocyte tumor necrosis factor alpha and interleukin-1beta production induced by direct contact with T lymphocytes: implications in rheumatoid arthritis.
    Dai SM; Matsuno H; Nakamura H; Nishioka K; Yudoh K
    Arthritis Rheum; 2004 Feb; 50(2):432-43. PubMed ID: 14872485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo blockade of tumor necrosis factor-alpha in patients with rheumatoid arthritis: longterm effects after repeated infusion of chimeric monoclonal antibody cA2.
    Lorenz HM; Grünke M; Hieronymus T; Antoni C; Nüsslein H; Schaible TF; Manger B; Kalden JR
    J Rheumatol; 2000 Feb; 27(2):304-10. PubMed ID: 10685789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-18-induced expression of intercellular adhesion molecule-1 in human monocytes: involvement in IL-12 and IFN-gamma production in PBMC.
    Yoshida A; Takahashi HK; Nishibori M; Iwagaki H; Yoshino T; Morichika T; Yokoyama M; Kondo E; Akagi T; Tanaka N
    Cell Immunol; 2001 Jun; 210(2):106-15. PubMed ID: 11520077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term treatment with etanercept significantly reduces the number of proinflammatory cytokine-secreting peripheral blood mononuclear cells in patients with rheumatoid arthritis.
    Schotte H; Schlüter B; Willeke P; Mickholz E; Schorat MA; Domschke W; Gaubitz M
    Rheumatology (Oxford); 2004 Aug; 43(8):960-4. PubMed ID: 15026584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of clarithromycin on costimulatory molecule expression and cytokine production by synovial fibroblast-like cells.
    Matsuoka N; Eguchi K; Kawakami A; Tsuboi M; Kawabe Y; Aoyagi T; Nagataki S
    Clin Exp Immunol; 1996 Jun; 104(3):501-8. PubMed ID: 9099936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of treatment with a fully human anti-tumour necrosis factor alpha monoclonal antibody on the local and systemic homeostasis of interleukin 1 and TNFalpha in patients with rheumatoid arthritis.
    Barrera P; Joosten LA; den Broeder AA; van de Putte LB; van Riel PL; van den Berg WB
    Ann Rheum Dis; 2001 Jul; 60(7):660-9. PubMed ID: 11406520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood monocyte activation in rheumatoid arthritis: increased monocyte adhesiveness, integrin expression, and cytokine release.
    Lioté F; Boval-Boizard B; Weill D; Kuntz D; Wautier JL
    Clin Exp Immunol; 1996 Oct; 106(1):13-9. PubMed ID: 8870692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine expression, upregulation of intercellular adhesion molecule-1, and leukocyte infiltration in experimental tubulointerstitial nephritis.
    Tang WW; Feng L; Mathison JC; Wilson CB
    Lab Invest; 1994 May; 70(5):631-8. PubMed ID: 7910873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of persistent T cell hyporesponsiveness in vivo by monoclonal antibody to ICAM-1 in patients with rheumatoid arthritis.
    Davis LS; Kavanaugh AF; Nichols LA; Lipsky PE
    J Immunol; 1995 Apr; 154(7):3525-37. PubMed ID: 7897232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up of the changes in circulating cytokines, soluble cytokine receptors, and white blood cell subset counts in patients with rheumatoid arthritis (RA) after monoclonal anti-TNF alpha antibody therapy.
    Ohshima S; Saeki Y; Mima T; Sasai M; Nishioka K; Ishida H; Shimizu M; Suemura M; McCloskey R; Kishimoto T
    J Clin Immunol; 1999 Sep; 19(5):305-13. PubMed ID: 10535607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneous requirement of IkappaB kinase 2 for inflammatory cytokine and matrix metalloproteinase production in rheumatoid arthritis: implications for therapy.
    Andreakos E; Smith C; Kiriakidis S; Monaco C; de Martin R; Brennan FM; Paleolog E; Feldmann M; Foxwell BM
    Arthritis Rheum; 2003 Jul; 48(7):1901-12. PubMed ID: 12847684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.